Idoven is reinforced with talent from the pharmaceutical industry. The Spanish company, which has technology for the early detection of cardiovascular diseases, has signed on Daiichi Sankyo to its new director of life sciences operations to Jorge Fernández, as confirmed by Idoven to PlantaDoce.
The manager has a degree in Business Administration and has a master’s degree in Innovation and Entrepreneurship from the University of Valencia. In addition, Fernández has an MBA from Iese and another from Strathmore University (Kenya).
Idoven incorporates a professional with experience in the area of oncology and immunology
Before joining Idoven, Fernández was manager of commercial strategy in the oncology area at Daiichi Sankyo Spain. She is a Japanese pharmaceutical company that, in addition to its portfolio of oncology and cardiovascular disease medicines, is focused on developing innovative treatments for people with cancer and other diseases where there is significant unmet medical need.
The manager also previously worked for Rochea group in which he served as strategic insight manager in areas such as immunology and oncology.
Likewise, Fernández was part of Janssen, of Johnson & Johnson, where he was responsible for marketing in the area of oncohematology and health solutions. Previously, the manager was in Novo Nordisk as a business analyst.
Idoven closed a round of more than eighteen million euros last year
Idoven is a healthcare technology company focused on early detection and precision medicine for cardiovascular diseases. The company works with a platform with artificial intelligence (AI), Willemwhich improves the speed, consistency, and accuracy of electrocardiogram interpretation and prediction.
Idoven collaborates with leading pharmaceutical and medical device companies to develop AI-based innovations. In June 2022, the company raised financing for 18.5 million euros. The financing consisted of a round of twelve million euros co-led by the global investment fund of software Insight Partners, which has companies such as Twitter, Calm or Trivago in its portfolio; and by Northzone, known for being early investors in Spotify and Spring Health.
The round included the participation of Wayra, hub of innovation of Telefónica. also participated business angels existing Idoven names like Iker Casillas and the two former top executives of Apple and Amazon, Diego Piacentini and Sebastian Gunningham. This round was complemented by €6.5 million in grants and capital awarded by the EIC Accelerator program of the European Innovation Council.